Hai‐Kui Yang

528 total citations · 1 hit paper
22 papers, 390 citations indexed

About

Hai‐Kui Yang is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Hai‐Kui Yang has authored 22 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 14 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Hai‐Kui Yang's work include Synthesis and biological activity (8 papers), Cancer therapeutics and mechanisms (8 papers) and Quinazolinone synthesis and applications (6 papers). Hai‐Kui Yang is often cited by papers focused on Synthesis and biological activity (8 papers), Cancer therapeutics and mechanisms (8 papers) and Quinazolinone synthesis and applications (6 papers). Hai‐Kui Yang collaborates with scholars based in China, Macao and United States. Hai‐Kui Yang's co-authors include Wen‐Wei You, Pei‐Liang Zhao, Zhiling Zhou, Bei Zhang, Jiawen Cui, Qiu Li, Zhihua Xiao, Peng-Cheng Diao, Yanhong Li and Ruiqi Wang and has published in prestigious journals such as Biophysical Journal, Frontiers in Immunology and European Journal of Medicinal Chemistry.

In The Last Decade

Hai‐Kui Yang

22 papers receiving 389 citations

Hit Papers

Tumor immunotherapy resistance: Revealing the mechanism o... 2024 2026 2025 2024 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape
    2024 80 citations Jiawen Cui, Yao Li et al. Biomedicine & Pharmacotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hai‐Kui Yang China 10 173 135 101 83 36 22 390
Pei‐Chih Lee Taiwan 10 198 1.1× 164 1.2× 81 0.8× 23 0.3× 45 1.3× 15 359
Jiachen Wen China 10 127 0.7× 159 1.2× 77 0.8× 59 0.7× 27 0.8× 23 353
Qinhuai Lai China 11 149 0.9× 226 1.7× 143 1.4× 47 0.6× 32 0.9× 18 455
Daniel P. Camarco United States 13 118 0.7× 159 1.2× 127 1.3× 45 0.5× 51 1.4× 21 415
Teresa De Luca Italy 11 110 0.6× 316 2.3× 105 1.0× 53 0.6× 27 0.8× 19 494
Felix Kopp United States 4 81 0.5× 243 1.8× 44 0.4× 38 0.5× 24 0.7× 5 348
Marcin D. Tomala Poland 5 52 0.3× 177 1.3× 304 3.0× 123 1.5× 27 0.8× 6 446
Soo‐Yeon Hwang South Korea 10 57 0.3× 220 1.6× 115 1.1× 37 0.4× 65 1.8× 22 374
Hon Yan Kelvin Yip Australia 7 58 0.3× 177 1.3× 106 1.0× 21 0.3× 28 0.8× 9 321

Countries citing papers authored by Hai‐Kui Yang

Since Specialization
Citations

This map shows the geographic impact of Hai‐Kui Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hai‐Kui Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hai‐Kui Yang more than expected).

Fields of papers citing papers by Hai‐Kui Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hai‐Kui Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hai‐Kui Yang. The network helps show where Hai‐Kui Yang may publish in the future.

Co-authorship network of co-authors of Hai‐Kui Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Hai‐Kui Yang. A scholar is included among the top collaborators of Hai‐Kui Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hai‐Kui Yang. Hai‐Kui Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cui, Jiawen, Yao Li, Yang Yang, et al.. (2024). Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape. Biomedicine & Pharmacotherapy. 171. 116203–116203. 80 indexed citations breakdown →
2.
Lin, Weijie, et al.. (2023). Exploring the pharmacological mechanism of Wuzhuyu decoction on hepatocellular carcinoma using network pharmacology. World Journal of Clinical Cases. 11(27). 6327–6343. 3 indexed citations
3.
Xiao, Zhihua, Ruiqi Wang, Xuyan Wang, et al.. (2023). Impaired function of dendritic cells within the tumor microenvironment. Frontiers in Immunology. 14. 1213629–1213629. 52 indexed citations
4.
Lin, Weijie, Yang Yang, Ruiqi Wang, et al.. (2022). TRIB3 promoter 33 bp VNTR is associated with the risk of cerebrovascular disease in type 2 diabetic patients. Frontiers in Genetics. 13. 916281–916281. 1 indexed citations
5.
Wang, Ruiqi, Fazhong He, Qian Meng, et al.. (2021). Tribbles pseudokinase 3 (TRIB3) contributes to the progression of hepatocellular carcinoma by activating the mitogen-activated protein kinase pathway. Annals of Translational Medicine. 9(15). 1253–1253. 8 indexed citations
6.
Wang, Ruiqi, Wei Zhao, Hai‐Kui Yang, et al.. (2021). Single-Cell RNA Sequencing Analysis of the Heterogeneity in Gene Regulatory Networks in Colorectal Cancer. Frontiers in Cell and Developmental Biology. 9. 765578–765578. 6 indexed citations
7.
Qiu, Wentao, Hai‐Kui Yang, Ruiqi Wang, et al.. (2021). GRB10 rs1800504 Polymorphism Is Associated With the Risk of Coronary Heart Disease in Patients With Type 2 Diabetes Mellitus. Frontiers in Cardiovascular Medicine. 8. 728976–728976. 4 indexed citations
8.
Yang, Zichao, Hai‐Kui Yang, Zhonghuang Li, et al.. (2020). Computational studies of potent covalent inhibitors on wild type or T790M/L858R mutant epidermal growth factor receptor. European Journal of Pharmaceutical Sciences. 152. 105463–105463. 11 indexed citations
9.
Jiang, Ying, Zichao Yang, Siming Liu, et al.. (2020). The cytochrome P450 metabolic profiling of SMU-B in vitro, a novel small molecule tyrosine kinase inhibitor. Journal of Pharmaceutical and Biomedical Analysis. 188. 113400–113400. 2 indexed citations
10.
Yang, Hai‐Kui, Ying Jiang, Zichao Yang, et al.. (2019). Design, synthesis and biological evaluation of 2-amino-4-(1,2,4-triazol)pyridine derivatives as potent EGFR inhibitors to overcome TKI-resistance. European Journal of Medicinal Chemistry. 187. 111966–111966. 20 indexed citations
11.
Diao, Peng-Cheng, et al.. (2019). Facile one-pot synthesis, antiproliferative evaluation and structure-activity relationships of 3-amino-1H-indoles and 3-amino-1H-7-azaindoles. Bioorganic Chemistry. 88. 102914–102914. 12 indexed citations
12.
Yang, Hai‐Kui, et al.. (2019). Structure-Guided Development of Dual Inhibitors of EGFR and JNK to Treat GBM and NSCLC. Biophysical Journal. 116(3). 481a–481a. 1 indexed citations
13.
Zhang, Tingting, Hai‐Kui Yang, Zichao Yang, et al.. (2018). Sulfonated Compounds Bind with Prostatic Acid Phosphatase (PAP248–286) to Inhibit the Formation of Amyloid Fibrils. ChemistryOpen. 7(6). 447–456. 4 indexed citations
14.
Li, Qiu, Hai‐Kui Yang, Qi Sun, Wen‐Wei You, & Pei‐Liang Zhao. (2017). Design, synthesis and antiproliferative activity of novel substituted 2-amino-7,8-dihydropteridin-6(5H)-one derivatives. Bioorganic & Medicinal Chemistry Letters. 27(17). 3954–3958. 5 indexed citations
15.
16.
Li, Yanhong, Bei Zhang, Hai‐Kui Yang, et al.. (2016). Design, synthesis, and biological evaluation of novel alkylsulfanyl-1,2,4-triazoles as cis-restricted combretastatin A-4 analogues. European Journal of Medicinal Chemistry. 125. 1098–1106. 59 indexed citations
17.
Zhao, Pei‐Liang, Hai‐Kui Yang, Peng Chen, et al.. (2016). Design, synthesis and antiproliferative activity of novel 5-nitropyrimidine-2,4-diamine derivatives bearing alkyl acetate moiety. European Journal of Medicinal Chemistry. 118. 161–169. 11 indexed citations
18.
Zhang, Bei, Hai‐Kui Yang, Yang Liu, et al.. (2015). Design, Synthesis and Molecular Docking Studies of Novel Indole–Pyrimidine Hybrids as Tubulin Polymerization Inhibitors. Chemical Biology & Drug Design. 86(6). 1491–1500. 41 indexed citations
19.
Ma, Weifeng, Hai‐Kui Yang, Tianzhu Ma, et al.. (2014). One-pot synthesis and antiproliferative activity of novel 2,4-diaminopyrimidine derivatives bearing piperidine and piperazine moieties. European Journal of Medicinal Chemistry. 84. 127–134. 24 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pei‐Chih Lee Breakdown of academic impact, for papers by Jiachen Wen Breakdown of academic impact, for papers by Qinhuai Lai Breakdown of academic impact, for papers by Daniel P. Camarco Breakdown of academic impact, for papers by Teresa De Luca Breakdown of academic impact, for papers by Felix Kopp Breakdown of academic impact, for papers by Marcin D. Tomala Breakdown of academic impact, for papers by Soo‐Yeon Hwang Breakdown of academic impact, for papers by Hon Yan Kelvin Yip
Rankless by CCL
2026